Valproic acid-induced parkinsonism: Levodopa responsiveness with dyskinesia

被引:29
|
作者
Silver, Michael [1 ]
Factor, Stewart A. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Neurol, Wesley Woods Hlth Ctr, Atlanta, GA 30329 USA
关键词
Valproic acid; Valproate; Parkinsonism; Dyskinesia; REVERSIBLE PARKINSONISM; SODIUM VALPROATE; EPILEPSY;
D O I
10.1016/j.parkreldis.2013.03.016
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Valproic acid is a drug used for the treatment of a variety of psychiatric and neurological disorders. While it is well known to cause postural tremor, hyperammonemia, slowness, and sedation, it has also been described to occasionally cause a reversible form of parkinsonism. Materials and methods: A series of five cases is reported. Results: All patients were taking the drug for at least several months before onset of their parkinsonian symptoms. Parkinsonism was defined by the presence of bradykinesia, rigidity, postural instability, and resting tremor, but not postural or action tremor. After discontinuing their valproic acid, improvement was seen by all patients. The course of improvement took days to months after discontinuance. Two of these patients responded to dopaminergic therapy, with drug-induced dyskinesia observed in one. In another patient, valproic acid was thought to unmask underlying Parkinson's Disease; this patient benefited from levodopa as well. Conclusion: Valproic acid-induced parkinsonism can look identical to idiopathic parkinsonism. In all five cases, the relationship between the valproic acid use and parkinsonism was initially unclear because of the delayed and insidious onset. Our finding of levodopa responsiveness and dyskinesia added to the diagnostic confusion. This treatment responsiveness also set it apart from neuroleptic-induced parkinsonism. In all cases improvement of symptoms occurred after discontinuation of the offending medication. (c) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:758 / 760
页数:3
相关论文
共 50 条
  • [21] Cannabidiol Mitigates Valproic Acid-Induced Developmental Toxicity and Locomotor Behavioral Impairment in Zebrafish
    Licitra, Rosario
    Damiani, Devid
    Naef, Valentina
    Fronte, Baldassare
    Della Vecchia, Stefania
    Sangiacomo, Chiara
    Marchese, Maria
    Santorelli, Filippo M.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (09) : 4935 - 4946
  • [22] Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation
    Li, Michael H.
    Mestre, Tiago A.
    Fox, Susan H.
    Taati, Babak
    JOURNAL OF NEUROENGINEERING AND REHABILITATION, 2018, 15
  • [23] Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation
    Michael H. Li
    Tiago A. Mestre
    Susan H. Fox
    Babak Taati
    Journal of NeuroEngineering and Rehabilitation, 15
  • [24] Valproic Acid-Induced Thrombocytopenia-Related Spontaneous Systemic Bleeding
    Johnston, Jackie P.
    Nerenberg, Steven F.
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : 1 - 4
  • [25] Ameliorative effects of Edaravone against Valproic Acid-Induced kidney damage
    Bayrak, Bertan Boran
    Sancar, Serap
    Cakmak, Neziha Hacihasanoglu
    Bolkent, Sehnaz
    Yanardag, Refiye
    JOURNAL OF MOLECULAR HISTOLOGY, 2025, 56 (01)
  • [26] Prevention of valproic acid-induced neural tube defects by sildenafil citrate
    Tiboni, Gian Mario
    Ponzano, Adalisa
    REPRODUCTIVE TOXICOLOGY, 2015, 56 : 175 - 179
  • [27] Parkinsonism: A Rare Adverse Effect of Valproic Acid
    Muralidharan, Abilash
    Rahman, Jawaria
    Banerjee, Dipanjan
    Mohammed, Abdul Rub Hakim
    Malik, Bilal Haider
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [28] Topiramate increases the risk of valproic acid-induced encephalopathy
    Noh, Young
    Kim, Dong Wook
    Chu, Kon
    Lee, Soon-Tae
    Jung, Keun-Hwa
    Moon, Hye-Jin
    Lee, Sang Kun
    EPILEPSIA, 2013, 54 (01) : e1 - e4
  • [29] Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy
    Liang, Tiantian
    Lin, Chenquan
    Ning, Hong
    Qin, Fuli
    Zhang, Bikui
    Zhao, Yichang
    Cao, Ting
    Jiao, Shimeng
    Chen, Hui
    He, Yifang
    Cai, Hualin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [30] Complicated valproic acid-induced pancreatitis: a case report
    Joyau, C.
    Darnis, D.
    Hauet, Q.
    Mahe, J.
    Veyrac, G.
    Jolliet, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 121 - 121